findmyKOL

Anita Deswal, MD

Basic profile

The University of Texas MD Anderson Cancer Center

ORCIDNPI
RegionHouston, TX · South CentralSpecialtyCardiovascular DiseaseFocusCardiology
Last active 2023findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPaymentsNone reportedNIH funding2008–2011Why? →

Anita Deswal is a Cardiology physician affiliated with The University of Texas MD Anderson Cancer Center. OpenAlex indexes 603 publications with 31,593 citations (h-index 74); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
603publications

Distinct works indexed by OpenAlex, matched via ORCID.

31,593citations

Total citations across indexed works.

74h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials
1NIH grants · 2008–2011

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1515 Holcombe Blvd
Houston, TX 770304000

Telephone

713-792-6161

Provider last certified this registry record 13 Apr 2020.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    87.5%
    Statin26%
    Atorvastatin Calcium72%Rosuvastatin Calcium28%
    Part D<11 patients
    Calcium channel blocker17.6%
    Nifedipine Er76%Amlodipine Besylate24%
    Part D<11 patients

    + 7 more classes in this area

  • Blood & clotting

    4.8%
    Factor Xa inhibitor4.8%
    Eliquis100%
    Part D<11 patients
  • Nervous system

    3.8%
    Other nervous system drugs3.8%
    Vyndamax100%
    Part D<11 patients
Where care is delivered (Part B)91.1% facility · 8.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20082011 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”